Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#,UPC#or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.
Menu

Kadcyla 100mg Vial 1 by Genentech

NDC 50242-0088-01 UPC/GTIN No.3-50242-08801-5 Mfg.Part No.8801Genentech, Inc. USAThis Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).Genentech, Inc. USAImage 4 of Kadcyla 100mg Vial 1 by Genentech

Kadcyla 100mg Vial 1 by Genentech

$3585.49$3399.00

NDC No. 50242-0088-01 UPC/GTIN No. 3-50242-08801-5 MPN 8801 Only Physician,Pharmacy or Licensed Facility can order this Rx Item No. Rx213900 Kadcyla 100mg Vial 1 by Genentech Item No. 3213900 NDC No. 50242008801 UPC No. 350242088015 Other Name Kadcyla, trastuzumab emtansine Therapeutic Class Antineoplastic Agents Item Class Non Controlled Rx. Case Qnty: 84 Antineoplastic Agents Info Antineoplastic Agents Common Group Ado-Trastuzumab Emtansine Unit Dose Packaging? Item Form Vial If You Are A Pati

Have a question?

KADCYLA- ado-trastuzumab emtansine injection, powder, lyophilized, for solution
Genentech, Inc.

WARNING: HEPATOTOXICITY, CARDIAC TOXICITY, EMBRYO-FETAL TOXICITY
Do Not Substitute KADCYLA for or with trastuzumab. (2.1)
Hepatotoxicity: Serious hepatotoxicity has been reported, including liver failure and death in patients treated with KADCYLA. Monitor serum transaminases and bilirubin prior to initiation of KADCYLA treatment and prior to each KADCYLA dose. Reduce dose or discontinue KADCYLA as appropriate in cases of increased serum transaminases or total bilirubin. (2.2, 5.1)
Cardiac Toxicity: KADCYLA administration may lead to reductions in left ventricular ejection fraction (LVEF). Evaluate left ventricular function in all patients prior to and during treatment with KADCYLA. Withhold treatment for clinically significant decrease in left ventricular function. (2.2, 5.2)
? Embryo-Fetal Toxicity: Exposure to KADCYLA during pregnancy can result in embryo-fetal harm. Advise patients of these risks and the need for effective contraception (5.3, 8.1, 8.3).
1 INDICATIONS AND USAGE



KADCYLA ® , as a single agent, is indicated for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either:

Received prior therapy for metastatic disease, or
Developed disease recurrence during or within six months of completing adjuvant therapy.
2 DOSAGE AND ADMINISTRATION

2.1 Recommended Doses and Schedules
The recommended dose of KADCYLA is 3.6 mg/kg given as an intravenous infusion every 3 weeks (21-day cycle) until disease progression or unacceptable toxicity. Do not administer KADCYLA at doses greater than 3.6 mg/kg. Do not substitute KADCYLA for or with trastuzumab.

Closely monitor the infusion site for possible subcutaneous infiltration during drug administration [see Warnings and Precautions (5.10)].

First infusion: Administer infusion over 90 minutes. Patients should be observed during the infusion and for at least 90 minutes following the initial dose for fever, chills, or other infusion-related reactions [see Warnings and Precautions (5.5)].

Subsequent infusions: Administer over 30 minutes if prior infusions were well tolerated. Patients should be observed during the infusion and for at least 30 minutes after infusion.

NDC 50242-0088-01 UPC/GTIN No.3-50242-08801-5 Mfg.Part No.8801
Kadcyla 100mg Vial 1 by Genentech
NDC 50242-0088-01 UPC/GTIN No.3-50242-08801-5 Mfg.Part No.8801

Genentech, Inc. USA

Genentech, Inc. USA

This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).
ADO-TRASTUZUMAB EMTANSINE
This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).

Genentech, Inc. USA
Genentech, Inc. USA

Image 4 of Kadcyla 100mg Vial 1 by Genentech